US · Healthcare

Response Genetics Inc (RGDXQ)

Diagnostics & Research

Response Genetics Inc (RGDXQ) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RGDXQ

P/E ratio

18.00

Response Genetics Inc (RGDXQ) — FAQ

What is RGDXQ's P/E ratio?

The price-to-earnings (P/E) ratio for Response Genetics Inc (RGDXQ) is 18.00 (data as of 2026-05-23).

Does Response Genetics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Response Genetics Inc (RGDXQ). Check the MyAverix Finance app for the latest dividend data.

What sector is Response Genetics Inc in?

Response Genetics Inc (RGDXQ) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is RGDXQ listed on?

RGDXQ is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)